Immunity & Inflammation May 8 2026 Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address chronic rejection and carries long-term side effects including infection, malignancy, and metabolic disorders. Achieving donor-specific immune tolerance while minimizing global immunosuppression has become the central goal of transplant immunology. Regulatory T cells